Bulletin 2011/27 - European Patent Office
10.12.2012 • Views
Share Embed Flag

Bulletin 2011/27 - European Patent Office

Bulletin 2011/27 - European Patent Office

Bulletin 2011/27 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

(A61K) I.1(2)<br />

• Controlled release oxycodone compositions<br />

• Compositions d'oxycodone à libération<br />

contrôlée<br />

(71) Napp Pharmaceutical Holdings Limited,<br />

Cambridge Science Park Milton Road, Cambridge<br />

CB4 0AB, GB<br />

(72) Oshlack, Benjamin, Boca Raton, FL 33432,<br />

US<br />

Chasin, Mark, Monroe, NJ 08831, US<br />

Minongue, John Josepf, New York, NY<br />

10956, US<br />

Kaiko, Robert, F., Weston, CT 06883, US<br />

(74) Ehlich, Eva Susanne, Maiwald <strong>Patent</strong>anwalts<br />

GmbH Elisenhof Elisenstraße 3, 80335<br />

München, DE<br />

(62) 07100187.9 / 1 774 969<br />

04005576.6 / 1 438 959<br />

03006020.6 / 1 325 746<br />

02008249.1 / 1 258 246<br />

96102992.3 / 0 722 730<br />

92925406.8 / 0 576 643<br />

(51) A61K 31/496 (11) 2 340 834 A1<br />

A61K 9/20 A61K 9/28<br />

(25) En (26) En<br />

(21) 09180931.9 (22) 30.12.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

AL BA RS<br />

(54) • Erhöhte Löslichkeit von Ziprasidon<br />

• Enhanced Solubility of Ziprasidone<br />

• Solubilité améliorée de la ziprasidone<br />

(71) Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim<br />

Sirketi, Hosdere Mevki Tunc Caddesi, No:3<br />

Abdi Ibrahim Ilac Hadimkoy, 34555 Istanbul,<br />

TR<br />

(72) Farshi, Farhad, 34555, ISTANBUL, TR<br />

Avci, Recep, 34555, ISTANBUL, TR<br />

Narsisoglu, Nadin, 34555, ISTANBUL, TR<br />

Soylemez, Serdar, 34555, ISTANBUL, TR<br />

Koc, Fikret, 34555, ISTANBUL, TR<br />

(51) A61K 31/497 (11) 2 340 835 A1<br />

A61K 31/445 A61P 25/00<br />

(25) En (26) En<br />

(21) 10189723.9 (22) 22.01.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

(30) <strong>27</strong>.01.2006 US 763036 P<br />

(54) • Piperidin- und Piperazinderivate<br />

• Piperidine and piperazine derivatives<br />

• Dérivés de pipéridine et de pipérazine<br />

(71) M's Science Corporation, Kobe International<br />

Business Center, 5F 5-5-2, Minatojima-<br />

Minamimachi, Chuo-ku Kobe 650-0047, JP<br />

(72) Li, Xiaoyuan, Los Altos, CA 94024, US<br />

Sun, Connie, L., Palo Alto, CA 94303, US<br />

(74) Goodfellow, Hugh Robin, Carpmaels &<br />

Ransford One Southampton Row, London<br />

WC1B 5HA, GB<br />

(62) 07762989.7 / 1 976 525<br />

(51) A61K 31/497 (11) 2 340 836 A1<br />

A61K 31/60 A61P 31/12<br />

C07D 403/02<br />

(25) En (26) En<br />

(21) 10196857.6 (22) <strong>27</strong>.02.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

(30) <strong>27</strong>.02.2006 US 777221 P<br />

(54) • Co-kristalle enthaltend VX-950 und deren<br />

pharmazeutische Zusammensetzungen<br />

• Co-crystals comprising VX-950 and their<br />

pharmaceutical compositions<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

• Co-cristaux comprenant VX-950 et leurs<br />

compositions pharmaceutiques<br />

(71) Vertex Pharmaceuticals Incorporated, 130<br />

Waverly Street, Cambridge, MA 02139-4242,<br />

US<br />

(72) Connelly, Patrick R., Harvard, MA 01451, US<br />

Morisette, Sherry, Belmont, MA 02478, US<br />

Tauber, Michael, Brighton, MA 01235, US<br />

(74) Cohausz & Florack, <strong>Patent</strong>- und Rechtsanwälte<br />

Partnerschaftsgesellschaft Bleichstraße<br />

14, 40211 Düsseldorf, DE<br />

(62) 07751732.4 / 1 991 229<br />

A61K 31/4985 → (51) A61K 31/165<br />

(51) A61K 31/517 (11) 2 340 837 A1<br />

A61K 31/00 A61P 35/00<br />

(25) En (26) En<br />

(21) 11155582.7 (22) 09.11.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

AL BA HR MK RS<br />

(<strong>27</strong>) 09.11.2006 EP 06819380<br />

(30) 11.11.2005 EP 05110669<br />

(54) • Kombinationsbehandlung gegen Krebs mit<br />

EGFR/HER2-Hemmern<br />

• Combination treatment of cancer comprising<br />

EGFR/HER2 inhibitors<br />

• Traitement combiné du cancer comprenant<br />

des inhibiteurs de EGFR/HER2<br />

(71) Boehringer Ingelheim International GmbH,<br />

Binger Strasse 173, 55216 Ingelheim am<br />

Rhein, DE<br />

(84) AT BE BG CH CY CZ DK EE ES FI FR GB GR<br />

HU IE IS IT LI LT LU LV MC NL PL PT RO SE<br />

SI SK TR<br />

(71) Boehringer Ingelheim Pharma GmbH & Co.<br />

KG, Binger Strasse 173, 55216 Ingelheim am<br />

Rhein, DE<br />

(84) DE<br />

(72) Solca, Flavio, 1230, Wien, AT<br />

Amelsberg, Andree, Danbury, CT 06810, US<br />

Van Meel, Jacobus C.A., 2340, Moedling, AT<br />

Baum, Anke, 1050, Wien, AT<br />

Stehle, Gerd, 89584, Ehingen, DE<br />

(74) Hammann, Heinz, et al, Boehringer Ingelheim<br />

GmbH Corporate <strong>Patent</strong>s Binger Strasse 173,<br />

55216 Ingelheim am Rhein, DE<br />

(62) 06819380.4 / 1 948 180<br />

(51) A61K 31/517 (11) 2 340 838 A1<br />

A61K 31/17 A61K 31/403<br />

A61K 31/475 A61P 35/00<br />

(25) En (26) En<br />

(21) 10182812.7 (22) 05.09.2002<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR IE IT LI LU MC NL PT SE SK TR<br />

(30) 05.09.2001 US 317302 P<br />

01.05.2002 US 376732 P<br />

(54) • Zusammensetzungen und deren Verwendung<br />

zur Behandlung von Krebs<br />

• Compositions and Methods of Treatment<br />

of Cancer<br />

• Compositions et procédés pour le traitement<br />

du cancer<br />

(71) Minerva Biotechnologies Corporation, 142<br />

Church Street, Newton, MA 02458, US<br />

(72) Bamdad, Cynthia, Waltham, 02451-1002, US<br />

(74) Cowley, Catherine Mary, et al, Venner Shipley<br />

LLP, 20 Little Britain, London EC1A 7DH, GB<br />

(62) 09159585.0 / 2 116 248<br />

0<strong>27</strong>97864.2 / 1 425 016<br />

A61K 31/519 → (51) A61K 31/202<br />

A61K 31/5365 → (51) C07D 505/24<br />

142<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>27</strong>/<strong>2011</strong>) 06.07.<strong>2011</strong><br />

A61K 31/5383 → (51) C07D 498/04<br />

A61K 31/541 → (51) C07D 498/04<br />

A61K 31/546 → (51) C07D 505/24<br />

A61K 31/55 → (51) A61K 9/20<br />

A61K 31/55 → (51) C07D 505/24<br />

(51) A61K 31/56 (11) 2 340 839 A1<br />

A61K 31/704 A61K 31/34<br />

A61K 31/192 A61K 31/4375<br />

A61K 31/35 A61K 31/70<br />

A61K 36/284 A61K 36/752<br />

A61K 36/28 A61K 36/25<br />

A61K 9/20 A61K 9/48<br />

A61K 9/16<br />

A61P 3/06<br />

A61K 9/14<br />

(25) Zh (26) En<br />

(21) 09811006.7 (22) 02.06.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK TR<br />

AL BA RS<br />

(86) CN 2009/072098 02.06.2009<br />

(87) WO 2010/025631 2010/10 11.03.2010<br />

(30) 05.09.2008 CN 200810198361<br />

(54) • ZUSAMMENSETZUNG VON PFLANZEN-<br />

EXTRAKTEN UND IHRE VERWENDUNG IN<br />

DER PROPHYLAXE ODER BEHANDLUNG<br />

VON STOFFWECHSELSTÖRUNGEN VON<br />

BLUTLIPIDEN<br />

• A COMPOSITION OF EXTRACTS FROM<br />

PLANTS AND THE USE THEREOF IN<br />

PROPHYLAXIS OR TREATMENT OF<br />

METABOLISM DISORDER OF BLOOD<br />

LIPID<br />

• COMPOSITION D'EXTRAITS DE PLANTES<br />

ET SON UTILISATION EN PROPHYLAXIE<br />

OU EN TRAITEMENT D'UN TROUBLE<br />

MÉTABOLIQUE DES LIPIDES SANGUINS<br />

(71) Guangdong Pharmaceutical University,<br />

No.280, Waihuan East Road Higher Education<br />

Mega Center Panyu, Guangzhou,<br />

Guangdong 510006, CN<br />

(72) GUO, Jiao, Guangzhou Guangdong 510006,<br />

CN<br />

BEI, Weijian, Guangzhou Guangdong<br />

510006, CN<br />

(74) Brown, David Leslie, Haseltine Lake LLP<br />

Redcliff Quay 120 Redcliff Street, Bristol BS1<br />

6HU, GB<br />

(51) A61K 31/59 (11) 2 340 840 A1<br />

A61P 17/06 A61P 17/12<br />

(25) En (26) En<br />

(21) 10184333.2 (22) 25.03.1999<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE<br />

(<strong>27</strong>) 25.03.1999 PCT/US99/06442<br />

(30) <strong>27</strong>.03.1998 US 79696 P<br />

(54) • Gepulste Dose von einem Vitamin D<br />

Wirkstoff zur Behandlung von hyperproliferativen<br />

Hauterkrankungen<br />

• Pulse dose Vitamin D drug for the treatment<br />

of hyperproliferative skin diseases<br />

• Dose pulsée d'une vitamin D pour le<br />

traitement de maladies d'hyperprolifération<br />

de la peau<br />

(71) OREGON HEALTH SCIENCES UNIVERSITY,<br />

3181 S.W. Sam Jackson Park Road, Portland,<br />

OR 97201-3098, US<br />

(72) Henner, William D, Portland, OR 97221, US<br />

Beer, Tomasz, M, Portland, OR 97215, US<br />

(74) Schlich, George William, et al, Schlich & Co<br />

34 New Road, Littlehampton West Sussex<br />

BN17 5AT, GB

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!